Title: Cvs Health Corp (CVS) 10K Annual Reports & 10Q SEC Filings
URL: https://last10k.com/sec-filings/cvs

HOME


LOGIN


PREMIUM


FREE TRIAL


SEC FILINGS


STOCK SCREENERS


EARNINGS


TRENDING


STOCKTWITS


INSIDER TRADING


SENTIMENT ANALYSIS


MANAGER PORTFOLIOS


LATE CORPORATE NEWS






				 



Cvs Health Corp (CVS) SEC Filing 10-K Annual Report for the fiscal year ending Sunday, December 31, 2023


Home
SEC Filings
Cvs Health Corp (CVS)
10-K Annual Report Wed Feb 07 2024






SEC Filings



 
CVS Valuations





Intrinsic Value





Financial Stability





Financial Ratios





Insider Trades





Manager Portfolios





Notifications





 
CVS Annual Reports
				  





10-K Annual Report February 2024


PDF

PDF


Select PDF Feature:
Include Exhibits
Highlight YoY Changes
Highlight Sentiment

10-K Only


Word
Excel
CSV


Table of Contents
Business
Risk Factors
Unresolved Staff Comments
Cybersecurity
Properties
Legal Proceedings
Mine Safety Disclosures
Information about our Executive Officers
Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Reserved
Managements Discussion and Analysis of Financial Condition and Results of Operations
Quantitative and Qualitative Disclosures About Market Risk
Financial Statements and Supplementary Data
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
Controls and Procedures
Other Information
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Directors, Executive Officers and Corporate Governance
Executive Compensation
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Certain Relationships and Related Transactions, and Director Independence
Principal Accountant Fees and Services
Exhibits and Financial Statement Schedules
Form 10K Summary
Signatures








									10-K Annual Report February 2023																






									10-K Annual Report February 2022																






									10-K Annual Report February 2021																






									10-K Annual Report February 2020																






									10-K Annual Report February 2019																






									10-K Annual Report February 2018																






									10-K Annual Report February 2017																






									10-K Annual Report February 2016																






CVS Quarterly Reports
				  





									10-Q Quarterly Report August 2024																






									10-Q Quarterly Report May 2024																






									10-Q Quarterly Report November 2023																






									10-Q Quarterly Report August 2023																






									10-Q Quarterly Report May 2023																






									10-Q Quarterly Report November 2022																






									10-Q Quarterly Report August 2022																






									10-Q Quarterly Report May 2022																






									10-Q Quarterly Report November 2021																






									10-Q Quarterly Report August 2021																






CVS Corporate News
				  





									Earnings ReleaseEvent for OfficersFinancial ExhibitRegulated Disclosure																	October 2024







									Earnings ReleaseFinancial Exhibit																	August 2024







									Event for OfficersFinancial ExhibitVote of Security Holders																	May 2024







									Financial ExhibitOther Events																	May 2024







									Financial ExhibitOther Events																	May 2024







									Earnings ReleaseFinancial Exhibit																	May 2024







									Regulated Disclosure																	March 2024







									Earnings ReleaseFinancial Exhibit																	February 2024







									Earnings ReleaseEvent for OfficersFinancial ExhibitRegulated Disclosure																	January 2024







									Financial ExhibitRegulated Disclosure																	December 2023













Last10K.com | 10-K Annual Report Wed Feb 07 2024






Cvs Health Corp


													CIK: 64803
																										Ticker: CVS




Earnings Press Release
 10-K Annual Report
 10-K YoY Changes
 Annual Proxy




Cvs Health Corp

HISTORY
TOOLS


CIK: 64803
Ticker: CVS




                   Exhibit 99.1CVS HEALTH REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTSWOONSOCKET, RHODE ISLAND, February 7, 2024 - CVS Health Corporation (NYSE: CVS) today announced operating results for the three months and year ended December 31, 2023.FOURTH QUARTER HIGHLIGHTSKEY FINANCIAL DATA•Total revenues increased to $93.8 billion, up 11.9% compared to prior year•GAAP diluted EPS of $1.58 and Adjusted EPS of $2.12FULL-YEAR HIGHLIGHTS•Total revenues increased to $357.8 billion, up 10.9% compared to prior year•GAAP diluted EPS of $6.47 and Adjusted EPS of $8.74•Generated cash flow from operations of $13.4 billionThree Months Ended December 31,In millions, except per share amounts20232022ChangeTotal revenues $93,813 $83,846 $9,967 Operating income3,373 3,659 (286)Adjusted operating income (1)4,227 4,079 148 Diluted earnings per share $1.58 $1.77 $(0.19)Adjusted EPS (2)$2.12 $2.04 $0.08 Note: Financial information as of and for the three months and year ended December 31, 2022 throughout this press release has been revised to conform with certain current period financial statement changes as described on page 16.2024 FULL-YEAR GUIDANCEUpon finalizing the medical cost trend analysis for the fourth quarter of 2023 and recognizing potential implications for elevated medical cost trends in 2024, the Company has:•Revised GAAP diluted EPS guidance to at least $7.06 from at least $7.26 •Revised Adjusted EPS guidance to at least $8.30 from at least $8.50  •Revised cash flow from operations guidance to at least $12.0 billion from at least $12.5 billionCEOCommentary“With a focus on delivering care and value, we had a strong fourth quarter and full year in 2023 as we build a world of health around every consumer. We will continue to drive affordable access to care when, where, and how people want, while we improve transparency throughout the health care system.”-Karen S. Lynch, CVS Health President and CEOIN THE SPOTLIGHTAnnounced CVS CostVantageTM, which evolves our pharmacy reimbursement model and brings greater transparency and simplicity to the system. CVS CostVantage will define the drug cost and related reimbursement using a simplified formula built on the cost of the drug, a set markup and a fee that reflects the care and value of pharmacy services. CVS Pharmacy plans to launch CVS CostVantage to commercial payors in 2025.Introduced CVS Caremark TrueCostTM, a model innovation that offers client pricing reflecting the true net cost of prescription drugs, with visibility into administrative fees. Simplified pricing will allow members to have stable access to the Company’s national pharmacy network. CVS Caremark plans to launch CVS Caremark TrueCost in 2025.Launched CVS HealthspireTM, the new name for the Health Services segment, which includes Caremark, CordavisTM, Oak Street Health, Signify Health and MinuteClinic®. CVS Healthspire will continue to focus on integration across the Company’s assets to deliver connected patient care, pharmacy benefits and innovative provider support solutions.  Announced a 10% increase to the quarterly shareholder dividend, which became effective with the February 1, 2024 dividend distribution. Returned $3.1 billion to shareholders through dividends in 2023.   Investor Contact: Larry McGrath | Senior Vice President Business Development and Investor Relations | (800) 201-0938Media Contact: Ethan Slavin | Executive Director Corporate Communications | (860) 273-6095The Company presents both GAAP and non-GAAP financial measures in this press release to assist in the comparison of the Company’s past financial performance with its current financial performance. See “Non-GAAP Financial Information” beginning on page 11 and endnotes beginning on page 24 for explanations of non-GAAP financial measures presented in this press release. See pages 13 through 15 and page 23 for reconciliations of each non-GAAP financial measure used in this release to the most directly comparable GAAP financial measure.1The following information was filed by Cvs Health Corp (CVS) on Wednesday, February 7, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release. 

Please wait while we load the requested 10-K report or click the link below:https://last10k.com/sec-filings/report/64803/000006480324000007/cvs-20231231.htm


View differences made from one year to another to evaluate Cvs Health Corp's financial trajectory





Sample 10-K Year-over-Year (YoY) Comparison



Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cvs Health Corp.

Continue







Assess how Cvs Health Corp's management team is paid from their Annual Proxy





Screenshot example of actual Proxy Statement




Cvs Health Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors


Continue














SEC Filing Tools




 Sentiment
 Sections
 Exhibits
 Stats


 



 Rating					
Learn More










Filter Sentiment:



All






Positive




Negative





Filter Category:




All





Financial







M & A






Revenue






Legal






Mgmt Change






Other






Filter Subcategory:




All






Debt






Shares






Product






Income






Dividend






Expense





Earnings







Cash Flow






Other







 Inside Cvs Health Corp's 10-K Annual Report:


 Other - Other   Highlight
Within certain ratio ranges, regulators have increasing authority to take action as the RBC Ratio decreases.



 Financial - Debt   Highlight
The risks inherent in assessing the impairment of a debt security include the risk that market factors may differ from projections and the risk that facts and circumstances factored into the Company’s assessment may change with the passage of time.

 M & A - Other   Highlight
In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies.

 Other - Other   Highlight
Although management believes there is sufficient current and historical information available to record reasonable estimates for estimated inventory losses, it is possible that actual results could differ.

 Financial - Shares   Highlight
Under the terms of the ASR, the maximum number of shares that could be delivered to the Company is 73.9 million.

 Financial - Debt
For unrealized losses determined to...Read more

 Other - Other
This legislative and regulatory activity...Read more

 Revenue - Product
The decrease was primarily due...Read more

 Financial - Debt
Although the Company currently believes...Read more

 Other - Other
The decrease was primarily due...Read more

 Financial - Income
The increase in adjusted operating...Read more

 Revenue - Product
The decrease was primarily driven...Read more

 Other - Other
The net proceeds of these...Read more

 Other - Other
The total reserve for estimated...Read more

 Other - Other
The main driver of this...Read more

 Financial - Dividend
In December 2023, the Board...Read more

 Other - Other
The Health Care Benefits segment...Read more

 Revenue - Product
The Company records revenue net...Read more

 Financial - Expense
However, based on historical claim...Read more

 Financial - Expense
During the second quarter of...Read more

 Financial - Expense
•Operating expenses in the Health...Read more

 Other - Other
PBM solutions include plan design...Read more

 Other - Other
These increases were partially offset...Read more

 Financial - Income
Effective January 1, 2023, the...Read more

 Revenue - Product
For contracts under which the...Read more

 Other - Other
The Company controls prescriptions fulfilled...Read more

 Financial - Shares
At the time they were...Read more

 Other - Other
As of December 31, 2023 and...Read more

 Legal - Other
•The Company’s pharmacy claims processed...Read more

 Revenue - Product
The increase was primarily driven...Read more

 Revenue - Product
•Revenues generated from prescription drugs...Read more

 Revenue - Product
Although intangible assets contribute to...Read more

 Other - Other
•Medical membership as of December 31,...Read more

 Other - Other
In August 2021, the Company...Read more

 Revenue - Product
•Total revenues increased $14.3 billion,...Read more

 M & A - Other
The net proceeds of these...Read more

 Revenue - Product
Revenue related to the Company’s...Read more

 Other - Other
During 2023, approximately 74% of...Read more

 M & A - Other
In connection with the development...Read more

 Revenue - Product
Some of the Company’s Government...Read more

 Financial - Shares
Over the long term, the...Read more

 Financial - Income
Prior to January 1, 2023,...Read more

 Other - Other
The RBC framework described above...Read more

 Financial - Expense
•Operating expenses in the Health...Read more

 Financial - Expense
•Interest expense increased $371 million,...Read more

 Financial - Income
The decrease in adjusted operating...Read more

 M & A - Other
The increase was primarily driven...Read more

 Other - Other
These decreases were partially offset...Read more

 Financial - Debt
These covenants do not include...Read more

 Other - Other
During the fourth quarter of...Read more

 Financial - Expense
The Company is creating new...Read more

 Financial - Expense
The Pharmacy & Consumer Wellness...Read more

 Other - Other
On June 2, 2023, the...Read more

 Other - Other
These challenges included lower net...Read more

 Financial - Income
When this occurred, both the...Read more

 Other - Other
In May 2022, the Company...Read more

 Other - Other
TotalInsuredASCTotalMedical membership:Commercial4,252 14,087 18,339 3,136 13,896 17,032 Medicare Advantage3,460 — 3,460 3,270 — 3,270 Medicare Supplement1,343 — 1,343 1,363 — 1,363 Medicaid2,073 444 2,517 2,234 497 2,731 Total medical...Read more

 Financial - Income
•The increased use of generic...Read more

 Revenue - Product
The Company recognizes revenue using...Read more

 Other - Other
Goodwill is subject to annual...Read more

 Financial - Income
The CODM evaluates the performance...Read more

 Other - Other
In December 2021, the Company...Read more

 Revenue - Product
The increase was primarily driven...Read more

 Other - Other
The Company expects to prudently...Read more

 Revenue - Product
This fair value estimate is...Read more

 Other - Other
This segment will also provide...Read more

 Financial - Expense
The increase in operating expenses...Read more

 Other - Other
•Prescriptions filled represents the number...Read more

 Other - Other
The segment also conducts long-term...Read more

 Financial - Expense
When establishing reserves as of...Read more

 Other - Other
•Net cash provided by operating...Read more

 Other - Other
The Company had $200 million of...Read more

 Financial - Income
•The segment’s adjusted operating income...Read more

 Other - Other
Indefinite-lived intangible assets are tested...Read more

 Revenue - Product
•During 2022, the Company recorded...Read more

 Revenue - Product
Health Care Benefits revenue is...Read more

 Other - Other
The Company operates a group...Read more

 Other - Other
•Competitive pressures in the retail...Read more

 Financial - Income
The Company uses adjusted operating...Read more

 Other - Other
(2)The Company’s net realized capital...Read more

 M & A - Other
•Net cash used in investing...Read more

 Revenue - Product
During 2022, the loss on...Read more

 Other - Other
•Medical membership represents the number...Read more

 Financial - Earnings
The Health Care Benefits segment...Read more

 Other - Other
Such adjustments are reasonably estimable...Read more

 Revenue - Product
The 2025 Medicare Advantage rates,...Read more

 Other - Other
The Company has three operating...Read more

 Other - Other
During 2023 and 2022, the...Read more

 Revenue - Product
Same-store metrics provide management and...Read more

 Financial - Income
Effective for the first quarter...Read more

 Financial - Expense
Inventories are valued at the...Read more

 Financial - Expense
Management considers historical health care...Read more

 Other - Other
Management uses MBR to assess...Read more

 Revenue - Product
Final 2024 Medicare Advantage rates...Read more

 Revenue - Product
Effective January 1, 2023, same...Read more

 Other - Other
Plans must have a star...Read more

 Other - Other
Accordingly, the Company believes excluding...Read more

 Other - Other
MBR provides management and investors...Read more

 Other - Other
Excluding the impact of COVID-19...Read more

 Financial - Shares
This activity includes the share...Read more

 Legal - Other
These increases were partially offset...Read more

 Other - Other
The Health Services segment sells...Read more

 Other - Other
(2)Includes an adjustment to convert...Read more

 Other - Other
The Health Services segment’s clients...Read more

 Financial - Shares
Each of the share Repurchase...Read more

 Legal - Other
•Revenues generated from prescription drugs...Read more

 Other - Other
Both Signify Health and Oak...Read more

 Other - Other
On January 31, 2024, CMS...Read more

 Other - Other
Pursuant to the authorization under...Read more

 Other - Other
At December 31, 2023, all of...Read more

 Other - Other
The indefinite-lived intangible asset impairment...Read more

 Other - Other
The Health Services segment provides...Read more

 Revenue - Product
Effective January 1, 2023, pharmacy...Read more

 Revenue - Product
These assumptions and estimates primarily...Read more

 Other - Other
In addition, the Company created...Read more

 Financial - Income
The decrease in adjusted operating...Read more

 Other - Other
(4)Includes an adjustment to convert...Read more

 Financial - Dividend
The Company maintains capital levels...Read more

 Other - Other
As of December 31, 2023, the...Read more

 Financial - Debt
The Company’s debt ratings have...Read more

 Other - Other
The store impairment charge is...Read more

 Other - Other
The Company’s 2024 star ratings...Read more

 Other - Other
The Health Care Benefits segment’s...Read more

 M & A - Other
(2)Relocated stores are not included...Read more

 Revenue - Product
This metric provides management and...Read more

 Financial - Shares
At the conclusion of the...Read more

 Financial - Earnings
These estimates can be affected...Read more

 Other - Other
On March 31, 2023, CMS...Read more

 Other - Other
If the net book value...Read more

 Other - Other
Pursuant to the authorization under...Read more

 M & A - Other
Goodwill represents the excess of...Read more

 Revenue - Product
(2)Pharmacy network revenues relate to...Read more

 Other - Other
•The Pharmacy & Consumer Wellness...Read more

 Revenue - Product
The Company recognizes revenue when...Read more

 Financial - Shares
In February 2022, the Company...Read more

 M & A - Other
Effective for the 2023 annual...Read more

 Revenue - Product
Same store metrics exclude revenues...Read more

 Financial - Earnings
The fair values of the...Read more

 Revenue - Product
•Medical benefit ratio is calculated...Read more

 Other - Other
There are four levels of...Read more

 Other - Other
There were no impairment losses...Read more

 Other - Other
As part of this initiative,...Read more

 Other - Other
Definite-lived intangible assets are amortized...Read more

 M & A - Other
During the year ended December 31,...Read more

 Financial - Shares
In February 2023, the Company...Read more

 Other - Other
The impairment test is performed...Read more

 Other - Other
In addition, the Company provides...Read more

 Financial - Expense
•Operating expenses as a percentage...Read more

 Other - Other
As a result of this...Read more

 Other - Other
A long-lived asset impairment test...Read more

 Other - Other
The Company also announced the...Read more

 Financial - Expense
Additionally, intangible asset amortization expense...Read more

 Other - Other
Both the 2022 and 2021...Read more

 Revenue - Product
This metric provides management and...Read more

 Revenue - Product
This metric provides management and...Read more

 Legal - Other
The increase in the segment’s...Read more

 Other - Other
On October 13, 2023, CMS...Read more

 Financial - Shares
During the years ended December 31,...Read more

 Revenue - Product
These increases in operating income...Read more

 Legal - Other
PBM services performed in connection...Read more

 Revenue - Product
(2)Intersegment revenue eliminations relate to...Read more

 Revenue - Product
This metric provides management and...Read more

 Mgmt Change - Other
In connection with this initiative,...Read more

 Other - Other
•Gross capital expenditures remained relatively...Read more

 Financial - Debt
Unexpected changes to market factors...Read more

 Other - Other
•Utilization, particularly in Medicare Advantage...Read more

 Other - Other
•Generic dispensing rate is calculated...Read more

 Other - Other
Adjustments generally result from contract...Read more

 Other - Other
These increases were partially offset...Read more

 Other - Other
The Patient Protection and Affordable...Read more

 Legal - Other
The increase in the segment’s...Read more

 Other - Other
•The Company is exposed to...Read more

 Other - Other
(10)In 2021, the goodwill impairment...Read more

 Financial - Expense
The increase in operating expenses...Read more

 Other - Other
This adjustment reflects the fact...Read more

 M & A - Other
On May 2, 2023, the...Read more

 Other - Other
•Net cash provided by financing...Read more

 Other - Other
Although not all states had...Read more

 Other - Other
If the carrying value of...Read more

 Other - Other
This adjustment reflects the fact...Read more

 Financial - Debt
During the year ended December...Read more

 Other - Other
(5)In 2023 and 2022, the...Read more

 Other - Other
The Company maintains a level...Read more

 Revenue - Product
(6)In 2023 and 2022, the...Read more

 Other - Other
•Products for which the Company...Read more

 Revenue - Product
(8)In 2022, the gain on...Read more

 Financial - Earnings
The fair values of the...Read more

 Revenue - Product
•Revenues primarily relate to products...Read more

 Financial - Earnings
The amount of the credit-related...Read more

 Other - Other
•The Health Services segment’s generic...Read more

 Other - Other
The effect of adjustments between...Read more

 Financial - Shares
The ultimate number of shares...Read more

 Other - Other
(9)In 2021, the store impairment...Read more

 Other - Other
As of December 31, 2023, the...Read more

 Financial - Cash Flow
The Company believes its operating...Read more

 Revenue - Product
This metric provides management and...Read more

 Other - Other
The Health Care Benefits segment...Read more

 Other - Other
In connection with its new...Read more

 Other - Other
We evaluate and adjust our...Read more

 Financial - Expense
•Adjusted operating loss decreased $295...Read more

 Revenue - Product
Effective January 1, 2023, mail...Read more

 Revenue - Product
(3)Mail & specialty revenues relate...Read more

 Financial - Income
•The exclusion of the impact...Read more

 Legal - Other
The Company estimates these rebates...Read more

 M & A - Other
(3)In 2023, the acquisition-related transaction...Read more

 M & A - Other
Given the close proximity of...Read more

 Financial - Debt
Among the factors considered in...Read more

 Financial - Expense
Based on historical claim experience,...Read more

 Financial - Dividend
CVS Health Corporation has paid...Read more

 Other - Other
This trend, which the Company...Read more

 Other - Other
The Company sold Insured plans...Read more

 Financial - Earnings
The fair values of the...Read more

 M & A - Other
On May 2, 2023, the...Read more

 Other - Other
CVS Health Corporation, together with...Read more

 M & A - Other
The Health Care Delivery reporting...Read more

 Other - Other
Management uses these metrics to...Read more

 Other - Other
•Please see “Segment Analysis” later...Read more

 Financial - Expense
The increase was primarily driven...Read more

 Financial - Debt
The Company continuously assesses its...Read more

 Financial - Debt
The additional regulations and undertakings...Read more

 Legal - Other
(7)In 2022, the opioid litigation...Read more

 Other - Other
During the third quarter of...Read more

 Revenue - Product
•Front store same store sales...Read more

 Other - Other
When estimating these losses, a...Read more

 Other - Other
As a result of this...Read more

 Other - Other
The estimates are based on...Read more

 Financial - Expense
The Company’s estimates can be...Read more

 Financial - Earnings
Future dividend payments will depend...Read more

 M & A - Other
(1)The Company’s acquisition activities have...Read more

 Financial - Earnings
The long-lived asset impairment loss...Read more

 Other - Other
Excluding the impact of COVID-19...Read more

 Other - Other
Subsequent to the impairment charge...Read more

 Revenue - Product
•Please see “Segment Analysis” later...Read more

 Financial - Debt
If either case is true,...Read more

 Other - Other
The value of ending inventory...Read more

 Other - Other
During the third quarter of...Read more

 Other - Other
•The Company expects growth in...Read more

 Other - Other
In connection with its new...Read more

 Other - Other
The coronavirus disease 2019 (“COVID-19”)...Read more

 Financial - Expense
In evaluating whether a credit...Read more

 Other - Other
The determination of the fair...Read more

 Other - Other
As of December 31, 2023, the Company...Read more

 Legal - Other
After considering the claims paid...Read more

 Revenue - Product
The Company’s pharmacy benefit arrangements...Read more

 Other - Other
The maximum borrowing capacity available...Read more

 Other - Other
The Company utilized these updated...Read more

 Revenue - Product
Based on the increase in...Read more

 Other - Other
•Legislation and/or regulations seeking to...Read more

 Revenue - Product
The sale of the Thailand...Read more

 Financial - Expense
•The Company expects benefits from...Read more

 Revenue - Product
The carrying value of the...Read more

 Other - Other
As part of this review,...Read more

 Other - Other
External rating agencies use their...Read more

 Financial - Debt
The Company regularly reviews its...Read more

 Financial - Expense
If a debt security is...Read more

 Financial - Cash Flow
The fair value of the...Read more

 Other - Other
The Company’s accounting for inventory...Read more

 Financial - Expense
Health care cost trend rates...Read more

 Revenue - Product
Any cumulative effect of these...Read more

 Financial - Shares
During the year ended December 31,...Read more

 Revenue - Product
During the first quarter of...Read more

 Financial - Shares
These estimates can be affected...Read more

 Other - Other
The Company evaluates the recoverability...Read more

 Financial - Debt
The term loan agreement allows...Read more

 Financial - Expense
Management uses this metric to...Read more

 Financial - Expense
Management uses this metric to...Read more

 Financial - Income
These decreases were partially offset...Read more

 M & A - Other
During 2023, the Company completed...Read more

 Other - Other
Fair value is estimated by...Read more

 Financial - Expense
The decrease was primarily due...Read more

 Other - Other
The Company’s segments maintain separate...Read more

 Other - Other
Excluding the impact of COVID-19...Read more

 Financial - Cash Flow
The fair value of the...Read more

 Revenue - Product
If the pharmacy reimbursement pressure...Read more

 Financial - Expense
The decrease in operating expenses...Read more

 Financial - Dividend
Under applicable regulatory requirements and...Read more

 Other - Other
During the third quarter of...Read more

 Other - Other
In addition, marketplace dynamics and...Read more

 Other - Other
The Company does not believe...Read more

 M & A - Other
On March 29, 2023, the...Read more

 Other - Other
As a result, management determined...Read more

 Financial - Cash Flow
If required, an impairment loss...Read more

 Financial - Debt
Interest payments on long-term debt...Read more

 Other - Other
Prior period segment financial information...Read more

 Other - Other
During the fourth quarter of...Read more

 Financial - Expense
Also, during 2023 and 2022,...Read more

 Legal - Other
•Pharmacy claims processed represents the...Read more

 Other - Other
The Company adjusts its rebates...Read more

 Other - Other
In addition, marketplace dynamics and...Read more

 Legal - Other
•Generic dispensing rate is calculated...Read more

 Other - Other
The segment has considered the...Read more

 Other - Other
The impact has not been...Read more

 Revenue - Product
During 2022, the Company determined...Read more

 Financial - Expense
If a debt security is...Read more

 M & A - Other
These transactions were accounted for...Read more

 Other - Other
During the fourth quarter of...Read more

 Financial - Expense
•Operating expenses in the Pharmacy...Read more

 Other - Other
Indefinite-lived intangible assets are subject...Read more

 Other - Other
IBNR estimates are developed using...Read more

 Revenue - Product
(3)Same store sales and prescription...Read more

 Financial - Expense
•Please see “Segment Analysis” later...Read more

 Other - Other
The office real estate optimization...Read more

 Financial - Debt
In addition, at the Company’s...Read more

 Financial - Cash Flow
If the estimated future cash...Read more

 Other - Other
The Company analyzes all facts...Read more

 Financial - Expense
•Management and administrative expenses to...Read more

 Mgmt Change - Other
As a member, the subsidiary...Read more

 Financial - Debt
The credit facilities allow for...Read more

 Financial - Expense
•Operating expenses as a percentage...Read more

 Financial - Expense
Health care costs payable also...Read more

 Financial - Cash Flow
The impairment loss calculation compares...Read more

 Financial - Expense
•Future costs are influenced by...Read more

 Legal - Other
Management uses this metric to...Read more

 Revenue - Product
Based on the 2024 star...Read more

 Financial - Expense
These decreases were partially offset...Read more

 Financial - Shares
In particular, competitive pressures in...Read more

 Financial - Debt
During the years ended December 31,...Read more

 Revenue - Product
As of September 30, 2023,...Read more

 Financial - Expense
•Operating expenses as a percentage of...Read more

 Other - Other
The results of the impairment...Read more

 Other - Other
•Prescriptions filled increased 1.5% on...Read more

 Financial - Cash Flow
If indicators of impairment are...Read more

 Legal - Other
At December 31, 2023 and 2022,...Read more

 Financial - Expense
•Operating expenses as a percentage...Read more

 Other - Other
Accordingly, the Company believes excluding...Read more

 Other - Other
The results of the impairment...Read more

 Financial - Income
•The Company’s effective income tax...Read more

 Other - Other
At the time of delivery,...Read more

 Financial - Shares
•Competitive pressures in the PBM...Read more

 Revenue - Product
The decrease in operating expenses...Read more

 Financial - Shares
It is also possible, depending...Read more

 Revenue - Product
•During 2023 and 2022, the...Read more

 Other - Other
The results of the impairment...Read more

 Other - Other
The results of the impairment...Read more

 Financial - Expense
The decrease in operating expenses...Read more

 Other - Other
Management uses this metric to...Read more

 Financial - Expense
Management uses this metric to...Read more

 Other - Other
These regulations are not directly...Read more

 Financial - Expense
(4)In 2023, the restructuring charges...Read more

 Revenue - Product
These capital gains and losses...Read more

 Financial - Cash Flow
The Company groups and evaluates...Read more

 Other - Other
These increases were largely offset...Read more



 
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report





Audit Information





Cover Page





Consolidated Balance Sheets





Consolidated Balance Sheets (Parenthetical)





Consolidated Statements Of Cash Flows





Consolidated Statements Of Cash Flows (Parenthetical)





Consolidated Statements Of Comprehensive Income





Consolidated Statements Of Operations





Consolidated Statements Of Shareholders' Equity





Consolidated Statements Of Shareholders' Equity (Parentheticals)





Acquisitions, Divestitures And Asset Sales





Acquisitions, Divestitures And Asset Sales (Tables)





Acquisitions, Divestitures And Asset Sales - Narrative (Details)





Acquisitions, Divestitures And Asset Sales - Schedule Of Estimated Fair Values Of Assets Acquired And Liabilities Assumed (Details)





Acquisitions, Divestitures And Asset Sales - Schedule Of Fair Value Of Consideration Transferred (Details)





Acquisitions, Divestitures And Asset Sales - Summary Of Fair Values And Weighted Average Useful Lives For Intangible Assets Acquired (Details)





Acquisitions, Divestitures And Asset Sales - Summary Of The Valuation Of Goodwill Allocated To Business Segments (Details)





Borrowings And Credit Agreements





Borrowings And Credit Agreements (Tables)





Borrowings And Credit Agreements - Debt Maturities (Details)





Borrowings And Credit Agreements - Long-Term Borrowings (Details)





Borrowings And Credit Agreements - Schedule Of Borrowings (Details)





Borrowings And Credit Agreements - Short-Term Borrowings (Details)





Commitments And Contingencies





Commitments And Contingencies (Details)





Earnings Per Share





Earnings Per Share (Details)





Earnings Per Share (Tables)





Fair Value





Fair Value (Tables)





Fair Value - Carrying Value And Fair Value Classified By Level (Details)





Fair Value - Changes In Level 3 Financial Assets (Details)





Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)





Fair Value - Measurement On A Recurring Basis (Details)





Fair Value - Narrative (Details)





Fair Value - Separate Accounts Fair Value (Details)





Goodwill And Other Intangibles





Goodwill And Other Intangibles (Tables)





Goodwill And Other Intangibles - Future Amortization Expense (Details)





Goodwill And Other Intangibles - Goodwill (Details)





Goodwill And Other Intangibles - Intangible Assets (Details)





Goodwill And Other Intangibles - Narrative (Details)





Health Care Costs Payable





Health Care Costs Payable (Tables)





Health Care Costs Payable - Components Of Change In Health Care Costs Payable (Details)





Health Care Costs Payable - Incurred And Paid Health Care Claims Development (Details)





Health Care Costs Payable - Liability For Unpaid Claims And Claims Adjustment Expense (Details)





Health Care Costs Payable - Narrative (Details)





Income Taxes





Income Taxes (Tables)





Income Taxes - Deferred Tax Assets And Liabilities (Details)





Income Taxes - Effective Tax Rate Reconciliation (Details)





Income Taxes - Income Tax Provision (Details)





Income Taxes - Narrative (Details)





Income Taxes - Unrecognized Tax Benefits (Details)





Insider Trading Arrangements





Investments





Investments (Tables)





Investments - Debt Securities (Details)





Investments - Debt Securities By Maturity (Details)





Investments - Mortgage Loan Principal Repayments (Details)





Investments - Mortgage Loans (Details)





Investments - Mortgage Loans Credit Ratings Indicator (Details)





Investments - Narrative (Details)





Investments - Net Investment Income (Details)





Investments - Realized Gains (Details)





Investments - Total Investments Schedule (Details)





Investments - Unrealized Loss Position (Details)





Investments - Unrealized Loss Position Maturities (Details)





Leases





Leases (Tables)





Leases - Maturities Of Operating And Finance Lease Liabilities (Details)





Leases - Narrative (Details)





Leases - Summary Of The Components Of Net Lease Cost (Details)





Leases - Supplemental Balance Sheet Information (Details)





Leases - Supplemental Cash Flow Information (Details)





Other Comprehensive Income (Loss)





Other Comprehensive Income (Loss) (Details)





Other Comprehensive Income (Loss) (Tables)





Other Insurance Liabilities And Separate Accounts





Other Insurance Liabilities And Separate Accounts (Tables)





Other Insurance Liabilities And Separate Accounts - Changes In Liability For Future Policy Benefits (Details)





Other Insurance Liabilities And Separate Accounts - Roll Forward Of Policyholders' Funds (Details)





Other Insurance Liabilities And Separate Accounts - Roll Forward Of Separate Accounts (Details)





Other Insurance Liabilities And Separate Accounts - Separate Account Assets (Details)





Other Insurance Liabilities And Separate Accounts - Undiscounted Expected Gross Premiums And Expected Future Benefit Payments (Details)





Other Insurance Liabilities And Separate Accounts - Weighted-Average Interest Rates And Durations (Details)





Pay Vs Performance Disclosure





Pension Plans And Other Postretirement Benefits





Pension Plans And Other Postretirement Benefits (Tables)





Pension Plans And Other Postretirement Benefits - Benefit Obligations And Plan Assets (Details)





Pension Plans And Other Postretirement Benefits - Changes In Level 3 Pension Plan Assets (Details)





Pension Plans And Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)





Pension Plans And Other Postretirement Benefits - Fair Value Of Pension Plan Assets (Details)





Pension Plans And Other Postretirement Benefits - Narrative (Details)





Pension Plans And Other Postretirement Benefits - Net Periodic Benefit Cost (Income) (Details)





Pension Plans And Other Postretirement Benefits - Weighted Average Assumptions Used (Details)





Reinsurance





Reinsurance (Tables)





Reinsurance - Effects Of Reinsurance (Details)





Reinsurance - Narrative (Details)





Reinsurance - Reinsurance Recoverables (Details)





Restructuring Program





Restructuring Program (Tables)





Restructuring Program - Change In Severance And Employee-Related Restructuring Charge Liability (Details)





Restructuring Program - Narrative (Details)





Segment Reporting





Segment Reporting (Tables)





Segment Reporting - Narrative (Details)





Segment Reporting - Reconciliation From Operating Income To Adjusted Operating Income (Details)





Segment Reporting - Reconciliation Of Financial Measures Of Segments To Consolidated Totals (Details)





Segment Reporting - Retrospective Adjustments To Segment Composition (Details)





Shareholders' Equity





Shareholders' Equity (Tables)





Shareholders' Equity - Accelerated Share Repurchases (Details)





Shareholders' Equity - Dividends (Details)





Shareholders' Equity - Noncontrolling Interests (Details)





Shareholders' Equity - Regulatory Requirements (Details)





Shareholders' Equity - Share Repurchases (Details)





Significant Accounting Policies





Significant Accounting Policies (Policies)





Significant Accounting Policies (Tables)





Significant Accounting Policies - Accounts Receivable (Details)





Significant Accounting Policies - Adjustments Resulting From Applying New Accounting Standard (Details)





Significant Accounting Policies - Cash And Cash Equivalents, Restricted Cash And Cash Equivalents (Details)





Significant Accounting Policies - Changes In Balances Of Long-Duration Insurance Liabilities (Details)





Significant Accounting Policies - Contract Balances (Details)





Significant Accounting Policies - Deferred Acquisition Costs (Details)





Significant Accounting Policies - Disaggregation Of Revenue (Details)





Significant Accounting Policies - Narrative (Details)





Significant Accounting Policies - New Accounting Pronouncements Recently Adopted (Details)





Significant Accounting Policies - Property And Equipment (Details)





Significant Accounting Policies - Receivables And Contract Balances (Details)





Significant Accounting Policies - Variable Interest Entities (Details)





Stock Incentive Plans





Stock Incentive Plans (Tables)





Stock Incentive Plans - Narrative (Details)





Stock Incentive Plans - Restricted Stock Unit And Performance Stock Unit Activity (Details)





Stock Incentive Plans - Stock Option And Sar Activity (Details)





Stock Incentive Plans - Stock-Based Compensation Expense (Details)





Stock Incentive Plans - Valuation Assumptions (Details)




 
Material Contracts, Statements, Certifications & more
Cvs Health Corp provided additional information to their SEC Filing as exhibits





Exhibit 4.29: Instruments Defining The Rights Of Security Holders, Including Indentures





Exhibit 10.22: Material Contract





Exhibit 10.45: Material Contract





Exhibit 10.47: Material Contract





Exhibit 10.53: Material Contract





Exhibit 10.54: Material Contract





Exhibit 21.1: Subsidaries Of The Registrant





Exhibit 23.1: Consents Of Experts And Counsel





Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification





Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification





Exhibit 32.1: Section 1350 Certification





Exhibit 32.2: Section 1350 Certification





Exhibit 97.1: Ex-97.1






Ticker: CVS CIK: 64803
Form Type: 10-K Annual Report
Accession Number: 0000064803-24-000007
Submitted to the SEC: Wed Feb 07 2024 6:52:35 AM EST
Accepted by the SEC: Wed Feb 07 2024
Period:  Sunday, December 31, 2023
Industry: Retail Drug Stores And Proprietary Stores						
External Resources:
 Stock Quote
 Social Media
 SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/cvs/0000064803-24-000007.htm








About 
											Contact 
											Help 
											API 
											Privacy 
											Terms 
									


© 2012 - 2024 Last10K.com All Rights Reserved









×
You're Signed Out
Sign in for the full experience


Sign in
Join Now








Intrinsic Value Calculator








Screenshot of intrinsic value for AT&T (2019)




Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
Continue












Never Miss A New SEC Filing Again








Screenshot taken from Gmail for a new 10-K Annual Report




Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news
Continue












We Highlighted This SEC Filing For You








Screenshot taken from Wynn's 2018 10-K Annual Report




Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q
Continue












Widen Your SEC Filing Reading Experience








Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report




Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view
Continue












Uncover Actionable Information Inside SEC Filings








Screenshot taken from Lumber Liquidators 10-K Annual Report




Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
Continue












Adobe PDF, Microsoft Word, Excel and CSV Downloads








Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats




Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), Excel (XLSX) and Comma-Delimited (CSV) files for offline viewing, annotations and analysis
Continue












Adobe PDF, Microsoft Word, Excel and CSV Downloads








Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats




Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), Excel (XLSX) and Comma-Delimited (CSV) files for offline viewing, annotations and analysis
Continue












Financial Stability Report








Screenshot of financial stability report for Coco-Cola (2019)




Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
Continue












Get a Better Picture of a Company's Performance








Available Financial Ratios




Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years
Continue












See when company executives buy or sell their own stock








Screenshot taken from Euronet (EEFT)




Last10K.com Member Feature

Use our calculated cost dollar values to discover when and how much registered owners BUY, SELL or excercise their company stock OPTIONS aggregated from Form 4 Insider Transactions SEC Filings
Continue












See how institutional managers trade a stock








Screenshot taken from General Motors (GM)




Last10K.com Member Feature

View which hedge funds, pension / retirement funds, endowments, banks and insurance companies have increased or decreased their positions in a particular stock. Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more
Continue












FREE Financial Statements








Screenshot of actual balance sheet from company 10-K Annual Report




Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREE












SEC Filing Exhibit
 PDF Download



Loading SEC Filing Exhibit...








SEC Filing Financial Summary
 PDF Download
 Excel Download



Loading SEC Filing Financial Summary...

